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Objective: A meta-analysis of over 25 years of research into the relationship between post-myocardial infarction (MI) depression and cardiac
prognosis was conducted to investigate changes in this association over time and to investigate subgroup effects.
Method: A systematic literature search was performed (Medline, Embase and PsycINFO; 1975–2011) without language restrictions. Studies
investigating the impact of post-MI depression on cardiovascular outcome, defined as all-cause mortality, cardiac mortality and cardiac
events within 24 months after the index MI, were identified. Depression had to be assessed within 3 months after MI using established
instruments. Pooled odds ratios (ORs) were calculated using a random effects model.
Results: A total of 29 studies were identified, resulting in 41 comparisons. Follow-up (on average 16 months) was described for 16,889 MI
patients. Post-MI depression was associated with an increased risk of all-cause mortality [(OR), 2.25; 95% confidence interval [CI], 1.73–
2.93; Pb.001], cardiac mortality (OR, 2.71; 95% CI, 1.68–4.36; Pb.001) and cardiac events (OR, 1.59; 95% CI, 1.37–1.85; Pb.001). ORs
proved robust in subgroup analyses but declined over the years for cardiac events.
Conclusions: Post-MI depression is associated with a 1.6- to 2.7-fold increased risk of impaired outcomes within 24 months. This association
has been relatively stable over the past 25 years.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Keywords: Depression; Myocardial infarction; Prognosis; Mortality; Meta-analysis1. Introduction
Beginning in the 1980s, reports that psychosocial stress
and depression following myocardial infarction (MI) were
linked to prognosis accumulated [1–5]. The increasing
number of studies showing links between post-MI depres-⁎ Corresponding author. Tel.: +31 50 3613833.
E-mail address: anna.meijer@med.umcg.nl (A. Meijer).
0163-8343/© 2011 Elsevier Inc. Open access under the Elsevier OA license.
doi:10.1016/j.genhosppsych.2011.02.007sion and prognosis suggested that identifying and treating
depression in MI patients could contribute to improving
survival rates and overall prognosis.
In the 25 years since these first investigations, much
research has been done in this field, which has been
summarized in several meta-analyses [6–8]. This research
showed that depressed cardiac patients have an increased
risk of both fatal and nonfatal events (including patients with
depressive disorder and patients with elevated symptoms of
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with those without depression. Barth et al. [6] performed a
meta-analysis on 29 studies concerning patients with
coronary heart disease (CHD), most of which were MI
patients. They found that depression in MI patients was
associated with a 2.0 to 2.6 times higher risk of mortality.
Similarly, in a meta-analysis of 22 studies, Van Melle
et al. [8] found an increased risk of 2.0 to 2.5 of poor
cardiac or mortality outcomes within 2 years after an MI
in patients with depression compared with nondepressed
patients. The most recent meta-analysis by Nicholson et al.
[7] reviewed studies published up to 2004 and reported
that depressed post-MI patients had a 2.1 times higher risk
of mortality than nondepressed patients. Hence, in
summary, previous meta-analyses demonstrated that de-
pressed post-MI patients have a 2.0 to 2.6 times increased
risk of adverse outcomes compared with nondepressed
post-MI patients.
A fair number of important studies on post-MI depression
and (cardiac) prognosis have been published in the 7 years
since previous literature searches. In addition, none of the
existing meta-analyses have statistically investigated wheth-
er the association of depression with mortality or cardiac
events changes over time, as has been suggested earlier [8,9].
This is an important question, as new insights in study design
and statistical methodology as well as advances in the
treatment and prevention of MI in recent years can affect the
nature and strength of the association between post-MI
depression and prognosis.
Therefore, the main objective of this study was to perform
a new meta-analysis to summarize the association between
post-MI depression and prognosis, defined as all-cause
mortality, cardiac mortality and cardiac events that occurred
within 24 months after the index MI. A secondary goal was
to investigate whether the strength of the relationship
between depression and cardiac outcomes has changed
over the years and whether or not methodological factors
influence this relationship.2. Methods
2.1. Literature search
A literature search was performed on January 5, 2011,
to identify prognostic studies that investigated the
association between post-MI depression and (cardiovascu-
lar) prognosis published since our previous literature
search in January 2004 [8]. The combined search results
included literature published since 1975. Relevant articles
were selected from the electronic databases Medline
(PubMed), Embase and PsycINFO without language
restrictions. For this purpose, search terms related to
depression and MI were used and customized to the
search strategies of each database. Full-search strings for
each database are listed in Appendix 1. In addition to the
database searches, major reviews and relevant articleswere cross-referenced. When necessary, additional infor-
mation was requested from authors by e-mail.
2.2. Study selection
2.2.1. Inclusion and exclusion criteria
Studies that met the following criteria were eligible for
inclusion: patients were hospitalized for MI; a validated
depression rating scale or structured diagnostic interview
was used; depression was measured within 3 months after
the MI; studies were prospective, reporting on (cardiovas-
cular) prognosis in depressed versus nondepressed patients;
study outcome was all-cause mortality, cardiac mortality or
cardiac events; and the end point was within 24 months after
the index MI. For the end-point cardiac events, studies that
reported on cardiac death, cardiac arrest, recurrent MI,
cardiac rehospitalization or a combination of the above were
included. Depression was defined as either depressive
disorder or elevated symptoms of depression.
Selection of studies identified by the literature search was
done by three independent raters (J.v.M., P.d.J. and A.M.) in
two phases. First, a title abstract review was performed, in
which studies that clearly did not meet the inclusion criteria
were excluded. Second, full texts were retrieved and
reviewed for the articles that were selected as potentially
eligible for inclusion in the title–abstract review. In the
review process, reviews, meta-analyses, comments, letters,
editorials, case reports and design reports of studies as well
as studies that did not include depression as a mood state
(but, for example, ST-segment depression) were excluded.
Only studies on data of MI patients were included to
create a relatively homogeneous group of subjects. Further-
more, the end point was chosen to be within 2 years after MI,
as we were interested in relatively short-term effects of post-
MI depression on prognosis. Most mortality and new events
after MI occur within the first few months, so it was expected
that any association with post-MI depression would be
evident by 2 years. By using a 2-year follow-up period,
relevant studies with varying follow-up durations could best
be compared. If studies reported outcomes later than 2 years
after the index MI, authors were contacted to request data on
2-year outcomes.
When multiple articles were based on the same dataset,
those with the best methodological quality or those that were
most informative were selected (i.e., more subjects, longer
follow-up, etc.). However, when multiple articles were based
on the same subjects, but reported on different, not
overlapping outcomes, they were all included.
When studies included MI patients as a subgroup of acute
coronary syndrome, and it was recorded whether patients
had unstable angina or MI, the authors were asked for
depression and outcome data for MI patients only.
2.3. Quality assessment
Reporting the quality of studies included in meta-
analyses is recommended by experts [10], as the quality of
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quality of included studies. In addition, quality assessment
may be helpful in deciding which variables measured in
the studies of the meta-analysis could be used in subgroup
or sensitivity analyses. Therefore, included articles were
assessed according to the following six methodological
quality criteria: (1) sample size of each group (preferably
at least 25 patients per group); (2) representativeness of the
population (i.e., whether the sample had any specific
inclusion or exclusion criteria such as those based on age or
gender); (3) whether there was more than 25% loss to follow-
up; (4) whether studies controlled for at least three of the
following: hypertension, smoking, hypercholesterolemia,
diabetes mellitus, left ventricular ejection fraction (LVEF)
or previous MI; (5) whether clinical end points were scored
adequately, that is, by means of central death registry, chart
review or independent blinded end point committee and (6)Literature search Pubmed,
Embase, PsycINFO
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Fig. 1. Flowchart litewhether depression was measured using a structured
diagnostic interview or a self-report instrument.
2.4. Data analysis
Data analyses for the summary estimate of the odds ratios
(ORs) were performed separately for three outcomes: all-
cause mortality, cardiac mortality and cardiac events. First,
data from the included studies were pooled. Reported results
were converted into raw data (2×2 tables) and dichotomized
outcomes. Then, pooled ORs and 95% confidence intervals
(CIs) were calculated using MIX 1.7, a statistical package
designed for performing meta-analyses [11], using a random
effects model [12]. When studies reported both clinically
diagnosed major depressive disorder and depressive symp-
toms, data on major depressive disorder were included.
To test between-study variance, heterogeneity tests wereCross-referencing
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Table 1
Overview and summary of included studies
First author Year of
publication
N Mean age
(years)
% Female Instrument Cutoff Time post-MI
(days)
% Depression Outcome FU time
(months)
% Lost to
FU
Start data
collection
Ahern et al. [1] 1990 351 NA NA BDI NA 6–60 40 CE 12 1 1983
Carney et al. [13] 2009 1328 60 45 DISH/BDI BDI cutoff NA b28 69 ACM 24 NA 1996
De Jonge et al. [14] 2006 468 61 20 CIDI NA 90 25 CE 24 NA 1997
Denollet et al. [15] 2010 416 60 22 BDI NA 61 24 CE 24 0 2003
Doyle et al. [16] 2006 433 63 25 HADS-D/BDI-FS HADS-D N7;
BDI-FS N3
2–5 17 ACM 12 0 2003
Doyle et al. [17] 2010 285 61 20 HADS-D/BDI-FS HADS-D N7;
BDI-FS N3
2–4 27 CE 15 0 2006
Drago et al. [18] 2007 98 62 22 BDI/DSM-IV
structured interview
BDI ≥10 7-14 BDI: 34;
SCID: 14
ACM/CE 24 2 1999
Frasure-Smith et al. [19] 1999 896 59 32 BDI BDI ≥10 5–15 32 CM 12 0 1991
Frasure-Smith et al. [20] 1995 218 60 22 BDI/DIS BDI ≥10 5–15 BDI: 31;
DIS: 16
CE 12 0 1991
Irvine et al. [21] 1999 301 64 18 BDI BDI ≥10 6–45 33 ACM/CM 24 5 1990
Kaufmann et al. [22] 1999 331 65 34 DIS DIS ≥5 7 27 ACM 12 0 1995
Ladwig et al. [2] 1991 553 54 0 KSb-S 90% 17–21 14 CM/CE 6 0 1983
Lane et al. [23] 2000 284 63 25 BDI BDI ≥10 2–15 31 CM 12 1 1997
Lane et al. [24] 2001 272 63 25 BDI BDI ≥10 2–15 31 CE 12 6 1997
Lauzon et al. [25] 2003 550 60 21 BDI BDI ≥10 2–3 35 ACM/CE 12 0 1996
Lesperance et al. [26] 1996 222 60 22 BDI/DIS BDI ≥10 5–15 16 ACM 18 0 1991
Mayou et al. [27] 2000 344 63 27 HADS HADS N10 b3 8 ACM 18 0 1994
Nakatani et al. [28] 2005 1803 NA NA Zung SDS Zung SDS≥40 b90 48 CE 24 0 1999
Parakh et al. [29] 2008 284 64 43 BDI/SCID BDI ≥10 b5 27 ACM 24 0 1995
Parashar et al. [30] 2006 1881 61 32 PHQ PHQ ≥10 b31 27 ACM 6 NA 2003
Rafanelli et al. [31] 2003 61 61 17 Modified SCID/DCPR/
PSI
NA 30 11 CE 24 0 1995
Rumsfeld et al. [32] 2005 634 65 28 MOS-D MOS-D ≥0.06 3–14 23 ACM/CE 24 NA 1999
Shiotani et al. [33] 2002 1042 63 20 Zung SDS Zung SDS ≥40 63 42 CM/CE 12 1 1998
Silverstone [3] 1987 108 63 25 MADRS MADRS ≥14 1 44 ACM/CE 0.25 NA 1984
Smolderen et al. [34] 2009 2347 61 32 PHQ-9 PHQ ≥10 1–3 22 ACM/CE 24 2 2003
Sørensen et al. [35] 2006 761 59 24 MDI MDI cutoff NA ±7 10 ACM/CE 12 NA 1999
Steeds et al. [36] 2004 131 60 33 BDI-II BDI-II ≥12 ±7 47 ACM 24 NA 1999
Strik et al. [37] 2003 206 59 24 SCID NA 30 31 ACM/CE 6 0 1997
Sydeman [38] 1998 101 62 40 SCID/BDI BDI ≥10 2–7 5 CE 6 7 1996
Thombs et al. [39] 2008 416 61 25 BDI BDI ≥10 2–5 29 ACM 12 0 1997
Welin et al. [40] 2000 267 NA 16 Zung SDS Zung SDS ≥40 30 37 CM 24 3 1985
NA, not available; ACM, all-cause mortality; CM, cardiac mortality; CE, cardiac events; BDI, Beck Depression Inventory; BDI-FS, Beck Depression Inventory Fast Scale; CIDI, Composite International Diagnostic
Interview; DCPR, Diagnostic Criteria in Psychosomatic Research; DIS, Diagnostic Interview Schedule; DISH, Depression Interview and Structured Hamilton; DSM-IV, Diagnostic and Statistical Manual of Mental
Disorders version IV; HADS-D, Hospital Anxiety and Depression Scale–Depression; KSb-S, Klinische Selbstbeurteilungsskalen aus dem Münchner psychiatrische Informations-System; MADRS, Montgomery–
Åsberg Depression Rating Scale; MDI, Major Depression Inventory; MOS-D, Medical Outcomes Study–Depression; PHQ, Patient Health Questionnaire; PSI, Psychosocial Index; SCID, Structured Clinical
Interview for DSM; Zung SDS, Zung Self-rating Depression Scale.
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207A. Meijer et al. / General Hospital Psychiatry 33 (2011) 203–216performed using the Q and I2 statistics. Possible publication
bias was investigated using funnel plots and Egger tests.
Second, to investigate whether the association between
post-MI depression and cardiac prognosis changed over
time, individual, unadjusted ORs were used and changes
over time were investigated using STATA 11 (Statacorp LP,
College Station, TX, USA). Different meta-regression
models were applied to investigate whether there was any
trend in the ORs over time. Null, linear, quadratic and cubic
models were applied, and best-fitting models were selectedFig. 2. (A) Forest plot all-cause mortality. (B) Forest plousing the Schwarz Bayesian Information Criterion (BIC).
The year of the start of data collection (study start) was used
as independent variable instead of the year of publication, as
there may be a considerable time lag between the period a
study is performed and the time it is published. Analyses
were weighted for the number of subjects in each study, in
such a way that larger studies contributed more to the pooled
OR than smaller studies.
Third, subgroup analyses were performed in MIX 1.7 for
two methodological differences between studies: type oft cardiac mortality. (C) Forest plot cardiac events.
Fig. 2 (continued).
208 A. Meijer et al. / General Hospital Psychiatry 33 (2011) 203–216depression instrument (structured diagnostic interview vs.
self-rating) and number of subjects per study (dichotomized
smaller N vs. larger N). For each outcome, studies were
divided into subgroups, and separate ORs were calculated.
ORs were then compared with a χ2 test.3. Results
3.1. Literature search and selection
The literature search resulted in 6,095 unique titles/
abstracts. Cross-referencing and personal contacts resulted in
an additional 48 potentially eligible articles. After the review
and selection process, 31 articles reporting on 29 studies
were selected and included, reporting on 16,889 patients
(5,353 depressed and 11,536 nondepressed) and representing
41 different analyses. Most of the ineligible articles were
excluded because they were not based on original data, such
as reviews, case-reports and editorials; because they did not
select subjects based on the presence of MI; or because they
did not include depression as an emotional state or as a risk
factor for poor prognosis. Interrater reliability between the
two sets of reviewers (J.v.M.–P.d.J. and P.d.J.–A.M.) was
calculated for the full-text review (Cohen's k=0.80 and 0.86,
respectively). Fig. 1 is a flowchart of the search results.Ten authors were contacted to request additional
information. Requests were made for outcome data at 24
months post-MI, data for depressed patients only instead of
patients with depression or anxiety, duration of follow-up,
exact number of events in depressed versus nodepressed
groups, data on MI patients only instead of acute coronary
syndrome patients, timing of depression measurement after
the MI, year in which the study started, loss to follow-up
and which depression rating instrument was used. Seven
authors provided the requested information. Three authors
could not answer, or did not respond to the request, which
in these cases meant their studies could not be included in
the meta-analysis.
3.2. Main study characteristics
In Table 1, the main study characteristics of included
articles are summarized. Collectively, the combined samples
included 16,889 patients. Mean patient age at the time of the
index MI was 61 years (range, 54–65 years). Twenty-six
percent of patients were women, and mean follow-up time
was 16 months, ranging from 1 week to 24 months. The
proportion of patients with major depression or patients
scoring above the cutoff of self-rating instruments ranged
from 5 to 69% (average 28%). This proportion was relatively
209A. Meijer et al. / General Hospital Psychiatry 33 (2011) 203–216high in some studies, as they purposefully included more
depressed patients. The average percentage of all-cause
mortality was 9% (range, 2%–21%); cardiac mortality, 5%
(0.5%–10%) and cardiac events, 21% (range, 5%–47%).
3.3. Association between post-MI depression and prognosis
Seventeen studies, consisting of 10,362 patients, reported
on all-cause mortality. A total of 892 patients died within 2
years after the index MI. The pooled OR of all-cause
mortality after MI in 3,053 depressed patients compared with
7,309 nondepressed patients was 2.25 (95% CI, 1.73–2.93;
Pb.001; Fig. 2A). The studies were statistically heteroge-
neous [Q=30.15, P=.02; I2=46.93% (95% CI, 6.62–69.84)].
Cardiac mortality was reported in six studies, consisting
of 3,343 patients. A total of 119 patients died of cardiac
causes within 2 years after the index MI. The pooled OR of
cardiac mortality after MI in 1,091 depressed patients
compared with 2,252 nondepressed patients was 2.71 (95%
CI, 1.68–4.36; Pb.001; Fig. 2B). The six studies were
relatively homogeneous [Q=7.06, P=.22; I2=29.14 (95% CI,
0.00–70.97)].
Cardiac events (fatal and nonfatal) were reported in 18
studies, consisting of 10,119 patients. A total of 2,247
patients had another cardiac event within 2 years after the
index MI. The pooled OR of cardiac mortality after MI in
2,946 depressed patients compared with 7,173 nondepressed
patients was 1.59 (95% CI, 1.37–1.85; Pb.001; Fig. 2C).
The 18 studies were statistically homogeneous [Q=24.5,
P=.11; I2=30.64 (95% CI, 0–60.8)].
For the three meta-analyses, funnel plots and Egger
tests showed no evidence of publication bias. Table 2
summarizes the three meta-analyses, including the hetero-
geneity and publication bias tests. Funnel plots are shown
in Fig. 3A–C.
3.4. Adjusted associations
Eight studies reported associations adjusted for baseline
demographic and cardiac disease severity variables. These
adjusted and unadjusted ORs were compared to gain insight
into the role of cardiac disease severity and other confound-
ing variables in the association between post-MI depression
and prognosis. The studies reporting adjusted associations
were too few and heterogeneous to pool by meta-analysis.Table 2
Results meta-analyses, heterogeneity, and publication bias
Outcome Pooled
OR
95 % CI I2 (95% CI) Q (P) Egger
test (P)
All-cause
mortality
2.25⁎ 1.73–2.93 46.93
(6.62–69.84)
30.15 (.02) 0.99 (.13)
Cardiac
mortality
2.71⁎ 1.68–4.36 29.14
(0–70.97)
7.06 (.22) 1.35 (.46)
Cardiac
events
1.59⁎ 1.37–1.85 30.64
(0–60.80)
24.50 (.11) 0.64 (.20)
⁎ Pb.001.Therefore, adjusted and unadjusted associations as they were
reported in the original articles are simply listed in Table 3.
Note that the associations are not necessarily reported as ORs
but also as hazard ratios. However, when the frequency ofig. 3. (A) Funnel plot studies all-cause mortality. (B) Funnel plot studies
ardiac mortality. (C) Funnel plot studies cardiac events.
F
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Table 3
Adjusted association per study
Author Outcome Unadjusted association
(95% CI)
Adjusted association
(95% CI)
Variables adjusted for
Frasure-Smith
et al. [19]
Cardiac mortality OR, 3.23 (1.65–6.33) OR, 3.66 (1.68–7.99) Age, smoking, LVEF, non-Q-wave MI, Killip class
Frasure-Smith
et al. [20]
Cardiac events OR, 3.32a (1.69–6.53) OR, 1.99a (0.92–4.31) Previous MI, ACE inhibitors at discharge, previous
depression, anxiety
Ladwig et al.
[2]
Cardiac mortality OR, 6.31b (1.98–20.09) OR, 4.9b (NA) Recurrent MI, late potentials, dyspnea, occurrence of
triples or more complex arrhythmias in 24 h. Holter ECG
Lauzon et al.
[25]
Cardiac events HR, 1.68 (1.18–2.39) HR, 1.40 (1.05–1.86) Age, sex, prior MI, history of angina, anterior location
of infarct, diabetes mellitus, hypertension, smoking
Rumsfeld
et al. [32]
All-cause mortality
cardiac events
HR, 1.84 (1.20–2.83) HR, 1.71 (1.11–2.63) Sex, age, race, BMI, blood pressure, LVEF, prior heart
failure, prior MI, atrial fibrillation, reperfusion or
revascularization during hospitalization for index MI,
smoking, hypertension, diabetes, dyslipidemia, COPD,
stroke or TIA, renal failure, alcohol use, ACE/ARB,
β-blockers, diuretics, aspirin, statins
HR, 1.47 (1.00–2.15) HR, 1.41 (1.03–1.93)
Shiotani et al.
[33]
Cardiac events OR, 1.46 (1.11–1.92) OR, 1.41 (1.03–1.92) Age, gender, severity of MI, diabetes mellitus,
hypertension, smoking
Smolderen
et al. [34]
Cardiac events HR, 1.37 (1.16–161) HR, 1.23 (1.04–1.46) Age, sex, race, diabetes mellitus, prior CAD, stroke,
chronic renal or heart failure, chronic lung disease,
nonskin cancer, current smoking, BMI, marital status,
education, insurance status, working status, ST-elevation
AMI, LVEF, heart rate, angiography, revascularization,
percentage/number of quality of care indicators received
Sørensen et al.
[35]
All-cause
mortality
HR, 3.15 (1.22–8.17) HR, 1.10 (0.10–9.00) Age, single status, non-Q-wave infarction, LVEF,
workload (watts)
ACE, angiotensin-converting enzyme; ARB, Angiotensin Receptor Blocking Agents; BMI, body mass index; CAD, Coronary Artery Disease; COPD, chronic
obstructive pulmonary disease; TIA, transient ischemic attack; AMI, acute myocardial infarction.
a These numbers represent BDI depressive symptoms, while for the meta-analysis, Diagnostic Interview Schedule major depression was used.
b The authors distinguished between low, medium and high depression. The unadjusted OR is for high versus medium or low depression. The adjusted OR
is for low versus high depression.
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mortality or cardiac events, these numbers are roughly
comparable [41,42]. In seven of the eight studies, adjusted
associations were smaller than unadjusted associations. The
attenuation ranged from 4% to 65% and was, on average,
21%.3.5. Secondary analyses
3.5.1. Changes in ORs over time
There was no association between the year of study start
and the OR for the outcome all-cause mortality. Fig. 4A
shows the ORs against time. For the outcome cardiac
mortality, the number of studies (6) was too small to perform
a meta-regression.
There was a significant linear association between the
year of study start and the OR for the outcome cardiac events
[linear model F(1.13), P=.01, R2=0.29, BIC=58.12]. This
means that later studies generally reported lower ORs than
earlier studies. The linear model, however, was only slightly
better than the quadratic model [quadratic model F(2,43),
P=.02, R2=0.40, BIC=59.17]. When the analysis was rerun
without an outlier, again to assess the robustness of the
association, there was a superior model fit for the quadratic
association [quadratic model (F(2,42), R2=0.55, Pb.01,
BIC=31.49) vs. linear model (F(1,43), R2=0.46, Pb.01,BIC=32.37)]. This means that the decline was somewhat
stronger in the earlier years and weakened in the later years.
Overall, there was a decline in the OR of about 0.1 each year
(Fig. 4B).
3.6. Differences between structured diagnostic interviews
and self-rating instruments
For the outcome all-cause mortality, 6 studies (n=2,280)
used interview-based instruments to assess depression, and
11 studies (n=8,082) used self-report instruments. The OR
for interview-based instruments was 3.69 (95% CI, 2.05–
6.63; Pb.001), and for self-report instruments, it was 1.83
(95% CI, 1.51–2.23; Pb.001), which was significantly
different (χ2=2.22, P=.03).
All studies reporting on cardiac mortality used self-rating
instruments, so no subgroup analysis could be performed.
For the outcome cardiac events, 7 studies (n=1,260) used
interview-based instruments to assess depression, and 11
studies (n=8,859) used self-report instruments. The OR for
interview-based instruments was 1.96 (95% CI, 0.99–3.89;
Pb.05), and for self-report instruments, it was 1.53 (95%
CI, 1.35–1.73; Pb.001), which was not significantly
different (χ2=0.70, P=.48).
There were no changes in the frequency of use of self-
report instruments and interviews over time.
Fig. 4. (A) Association between the year of study start and OR for all-cause
mortality. (B) Association between the year of study start and OR for cardiac
events.
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Studies reporting on all-cause mortality were divided
into two subgroups. The subgroup of nine studies with
each less than 400 subjects contained 2,012 patients, and
the subgroup of eight studies with each more than 400
subjects contained 8,350 patients. The OR for the smaller
studies was 2.25 (95% CI, 1.38–3.66), and for the larger
studies, it was 2.30 (95% CI, 1.65–3.20). There was no
significant difference between the ORs (χ2=0.07, P=.94).
For the outcome cardiac mortality, the studies were again
divided into two subgroups. The subgroup of three studies
with each less than 330 subjects contained 852 patients, and
the subgroup of three studies with each more than 330
subjects contained 2,491 patients. The OR for the smaller
studies was lower than that for the larger studies [1.90 (95%
CI, 1.06–3.48; P=.03) vs. 3.92 (95% CI, 2.24–6.88]
Pb.001)], and this difference was not significant but showed
a trend (χ2=1.76, P=.08).Finally, studies reporting on cardiac events were divided
into two equal subgroups with nine studies. The subgroup of
nine studies with each less than 400 subjects contained 1,700
patients, and the subgroup of nine studies with each more
than 400 subjects contained 8,419 patients. The OR for the
smaller studies was higher than that for the larger studies
[1.74 (95% CI, 1.01–2.98; P=.04) vs. 1.53 (95% CI, 1.37–
1.71; Pb.001)]. The difference was not significant (χ2=0.45,
P=.65). Finally, for all three outcome types, there were no
changes of study size over time.
3.8. Quality assessment
Studies were evaluated on six quality aspects. First, the
preferred sample size was at least 25 patients in the
depressed and in the nondepressed groups. In all studies,
the number of nondepressed patients was over 25 (average
n=400; range, 54–1823). The number of depressed
patients was lower than 25 in three studies (average
n=175; range, 4–920). Second, studies were assessed on
representativeness of the population. The majority of
studies (19) did not have any unusual inclusion or
exclusion criteria. Exclusion criteria such as those based
on the presence of dementia, the presence of other major
psychiatric disorders and being unable to speak the
researchers' language were not considered unusual.
Third, it was assessed whether there was more than 25%
loss to follow-up. Thirteen studies did not have any loss to
follow-up. In the remaining studies, loss to follow-up was,
on average, 5% (range, 0.2%–17%), and none reported
loss to follow-up over 25%. Six studies did not report the
number of patients lost to follow-up. Fourth, it was
assessed whether studies adjusted for at least three of the
following cardiac risk factors in their adjusted analyses:
hypertension, smoking, hypercholesterolemia, diabetes
mellitus, LVEF or previous MI. Twelve analyses were
adjusted for at least three of these risk factors, 16 analyses
were not adjusted for at least three of these factors and 4
analyses were not adjusted or did not report the variables
they adjusted for. Fifth, it was assessed whether clinical
end points were scored adequately, that is, by means of
central death registry, chart review or independent blinded
end-point committee. Three studies did not report how
they scored the clinical end point, and three other studies
did not use an adequate method (but patient or family self-
reports only). Finally, it was assessed whether depression
was measured using a structured diagnostic interview or a
self-report instrument. The majority of the studies (17)
used self-rating instruments, six studies used a standard-
ized structured clinical interview and four studies used
both. An overview of the quality assessment of the
included articles is listed in Table 4.
The effects of the quality criteria on the association
between post-MI depression and prognosis for sample
size, type of depression measurement instrument and
adjustment for confounders were assessed in the
Table 4
Quality assessment included studies
Author and
article
Sample size Representativeness
of population
% lost to
follow-up
Factors controlled for Clinical end points
scored adequately
Type of depression
measurement
instrument
Ahern et al.
[1]
351 subjects N75 years and women
with child-bearing
potential excluded
1 LVEF, previous MI, β-blockers, digitalis, anxiety, anger,
social desirability, social support, mood states, type A–B
NA Self-rating
Carney et al.
[13]
1,328 subjects No unusual inclusion
or exclusion criteria
NA ENRICHD all-cause mortality risk score; initial BDI score;
SSRI use
Standardized, group-masked classification
of major end points, death certificates
Interview
De Jonge
et al. [14]
468 subjects No unusual inclusion
or exclusion criteria
0 Age, gender, education level, LVEF, revascularization Patient interviews, hospital records, data
from treating specialist, data from primary
care physician
Interview
Denollet et al.
[15]
416 subjects age b30 years
excluded
0 Age, gender, cardiac history, LVEF, invasive treatment,
statins, aspirin, diuretics, SSRIs, BMI
Medical records Self-rating
Doyle et al.
[16]
433 subjects No unusual inclusion
or exclusion criteria
0 Age, sex Primary care physicians for vital status, date
of death from national births, marriages
and deaths registry
Self-rating
Doyle et al.
[17]
285 subjects No unusual inclusion
or exclusion criteria
5 Age, sex, smoking, diabetes, history of CHD, history of
revascularization, length of hospital stay, LVEF
Medical records Self-rating
Drago et al.
[18]
98 subjects No unusual inclusion
or exclusion criteria
2 Age, gender, diabetes mellitus, dyslipidemia, previous AMI,
anterior AMI, nonpreserved LVEF, acute treatment with
thrombolysis or primary coronary angioplasty and HRV value
Medical examination, telephone interview or
ambulatory examination, death certificates
diagnosis for fatal events
Both
Frasure-Smith
et al. [19]
896 subjects No unusual inclusion
or exclusion criteria
0 Age, smoking, LVEF, non-Q-wave MI, Killip class Patient or family contacts, Quebec Medicare
data, 2 independent raters
Self-rating
Frasure-Smith
et al. [20]
222 subjects No unusual inclusion
or exclusion criteria
0 Anxiety, history of major depression, previous MI, LVEF,
Killip class, ACE inhibitors at discharge
Contacting patients, family members,
committee of cardiologists reviewed death
certificates, ambulance and hospital records
Both
Irvine et al.
[21]
301 subjects No unusual inclusion
or exclusion criteria
5 Previous MI, previous CHF, social participation, social
network contacts, dyspnea/fatigue
Blinded external validation committee Self-rating
Kaufmann
et al. [22]
331 subjects No unusual inclusion
or exclusion criteria
0 Ejection fraction, previous MI, CHF, CABG, previous
stroke, diabetes, age, hypertension, family history of CAD
Recontacting patients at home Interview
Ladwig et al.
[2]
553 subjects Female patients and
N66 years excluded
0 Recurrent MI, late potentials, dyspnea, occurrence of triplets
or more complex arrhythmias in 24-Holter ECG
Home physician, hospital physician,
relatives, bystanders
Self-rating
Lane et al. [23] 288 subjects No unusual inclusion
or exclusion criteria
6 Age, partner status, living alone, education, Peel index
score, Killip class, length of hospital stay
Hospital patient information system Self-rating
Lane et al. [24] 288 subjects No unusual inclusion
or exclusion criteria
1 Not stated Hospital and general practician records,
death certificates
Self-rating
Lauzon et al.
[25]
550 subjects No unusual inclusion
or exclusion criteria
0 Age, sex, prior MI, history of previous angina, anterior
location of infarct, diabetes mellitus, hypertension, smoking
Central death registry Self-rating
Lesperance
et al. [26]
222 subjects No unusual inclusion
or exclusion criteria
0 History of major depression, BDI N10, age N65 years Contacting patients or family members Interview
Mayou et al.
[27]
344 subjects No unusual inclusion
or exclusion criteria
0 NA Death certificates, autopsy records and
Office of National Statistics data
Self-rating
212
A
.
M
eijer
et
al.
/
G
eneral
H
ospital
P
sychiatry
33
(2011)
203–216
Nakatani et al.
[28]
1,803 subjects No unusual inclusion
or exclusion criteria
0 Age, sex, diabetes mellitus, hypertension, hyperlipidemia,
smoking, history of M, Killip class N or = II, anterior
infarction, reperfusion antiplatelet agents, ace inhibitors,
β-blockers
Research outpatient clinic, verbal or
written contact with patients or their
family members
Self-rating
Parakh et al.
[29]
284 subjects No unusual inclusion
or exclusion criteria
0 Age, diabetes, previous MI, Killip class, treatment of MI,
LVEF, Q-wave MI, creatine kinase, renal insufficiency, lung
disease, length of stay, aspirin use, physical function (SF-36)
Social Security Death Index Both
Parashar et al.
[30]
1,881 subjects No unusual inclusion
or exclusion criteria
11 Age, race, sex, medical history (diabetes, hypertension,
COPD, smoking, prior MI), severity of MI (ST-segment
elevation), LVEF
Contacts with family members, Social
Security Death Master File, patient contacts
Self-rating
Rafanelli et al.
[31]
61 subjects No unusual inclusion
or exclusion criteria
0 Age, sex, absolute CV risk (MI complications, LVEF,
residual ischemia, ventricular arrhythmias, smoking,
diabetes, hypertension, cholesterol, triglycerides, fibrinogen,
leukocytes, intermittent claudication, heart rate
NA Interview
Rumsfeld et al.
[32]
634 subjects Only patients with
heart failure included
NA Age, gender, race, BMI, systolic blood pressure, LVEF,
prior heart failure and MI, atrial fibrillation, reperfusion or
revascularization during hospitalization, smoking,
hypertension, diabetes mellitus, dyslipidemia, COPD, stroke
or TIA, renal failure, moderate to heavy alcohol use,
ACE/ARB, β-blockers, diuretics, aspirin, statins
All-cause mortality and cardiovascular
death or hospitalization adjudicated by a
blinded critical events committee
Self-rating
Shiotani et al.
[33]
1,042 subjects No unusual inclusion
or exclusion criteria
1 Age, diabetes mellitus, hypertension Hospital records, telephone interviews
with patients or family
Self-rating
Silverstone [3] 108 subjects No unusual inclusion
or exclusion criteria
NA None Not reported Interview
Smolderen
et al. [34]
2,347 subjects No unusual inclusion
or exclusion criteria
10–17 Age, sex, race, diabetes mellitus, prior coronary artery
disease, stroke, chronic renal failure, chronic lung disease,
chronic heart failure, nonskin cancer, current smoking, BMI,
marital status, education, insurance status, working status,
ST-elevation AMI, LVEF, heart rate, angiography,
revascularization, percent and number of quality of care
indicators received
Patient reports (telephone interview),
Social Security Death Master File
Self-rating
Sørensen et al.
[35]
761 subjects N76 years excluded NA Age above 65 years, being single, non-Q-wave infarction,
ejection fraction, 40% and high workload
National Register of Patients, National
Register of Causes of Death
Self-rating
Steeds et al.
[36]
131 subjects No unusual inclusion
or exclusion criteria
NA Size of MI, rate of thrombolysis, in-hospital complications
but not clear for: calcium antagonists, β-adrenoreceptor
antagonist at discharge
UK National Health Service central register Self-rating
Strik et al. [37] 318 subjects Females and patients
with previous MI
excluded
0 Age, LVEF, antidepressants Diagnosis by attending cardiologist Interview
Sydeman, [38] 101 subjects b35 years excluded 7 State anger, LVEF Patient reports Both
Thombs et al.
[39]
416 subjects No unusual inclusion
or exclusion criteria
0.20 age, Killip class, history of AMI, gender, marital status,
history of angina, diabetes, smoking
12-Month patient questionnaire,
patient/family reports, GP's and
specialist physicians
Self-rating
Welin et al.
[40]
275 subjects Patients with previous
MI excluded
3 Sex, LVEF, dyspnea after infarction, ventricular
dysrhythmia at 3 months, diabetes mellitus, social activities
Death certificate, physician diagnosis Self-rating
BMI, body mass index; AMI, acute myocardial infarction; ACE, angiotensin-converting enzyme; CABG, Coronary Artery Bypass Grafting; CAD, Coronary Artery Disease; CHF, chronic heart failure; COPD,
chronic obstructive pulmonary disease; CV, cardiovascular; ENRICHD, Enhancing Recovery in Coronary Heart Disease; HRV, Heart Rate Variability; SF-36, Short Form-36; SSRI, Selective Serotonin Reuptake
Inhibitor.
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size did not affect the strength of the association reported,
that studies using structured diagnostic interviews had
higher ORs for all-cause mortality than did studies using
self-rating instruments and that the association between
post-MI depression and prognosis was attenuated when
adjusted for confounders. The other quality criteria were
assessed in sensitivity analyses. These analyses revealed
no differences in results with regard to specific inclusion
or exclusion criteria, loss to follow-up or end-point
scoring method.4. Discussion
4.1. Association between post-MI depression and prognosis
Unadjusted ORs show that patients with a post-MI
depression have a 2.25 times increased risk of all-cause
mortality, a 2.71 times increased risk of cardiac mortality and
a 1.59 times increased risk of new cardiac events. These ORs
are similar to those found in earlier meta-analyses [6,7].
Individual adjusted associations were lower (on average,
21%) than unadjusted associations in all but one of the eight
studies reporting associations adjusted for baseline demo-
graphic and medical variables. This attenuation was found in
previous similar meta-analyses of the association between
depression in cardiac patients and prognosis. Ameta-analysis
of MI patients, for example, found a reduction in association
of 41% after adjustment for possible confounders [7] Others
also found a reduction, though less pronounced [6,8]. One
possible explanation may be reverse causality: depression
does not cause cardiac events or death, but the severity of the
cardiac disease causes both a poorer prognosis and more
depressive symptoms [7]. The fact, however, that after
adjustment for disease severity, depression is still associated
with poorer prognosis suggests that it is an independent risk
factor. Most likely, the association is bidirectional. In
addition, other variables, such as smoking and age, may
affect the association, not just as confounders, but also as
mediators of the association. When there is reverse causality
or confounding, the pooled ORs adjusted for disease severity
and other confounders will probably turn out lower than
unadjusted pooled ORs [43].
Unfortunately, we could not provide a pooled association
that is consistently adjusted for the same variables across
studies, as each study adjusts for a different set of variables.
The only way to solve this problem is to perform a meta-
analysis of individual patient data of the original studies and
adjust for the same variables.
4.2. Changes in ORs over time
ORs were expected to decline over time, and such a
decline was found for the outcome cardiac events, showing a
small but significant decline of about 0.1 for each
progressing year. This means that the apparent effect of
depression on new cardiac events has become smaller. Toolittle is known so far about the mechanisms of this
association to be able to explain this decline. For the
outcomes all-cause mortality and cardiac mortality, there
were no significant changes in ORs over time. No
mentionable changes were found in the frequencies of
mortality, cardiac events or depression that could help
explain the fact that the association did decline for cardiac
events, but not for mortality.
4.3. Subgroup analyses: depression measurement and
sample size
The two subgroup analyses, based on the type of
depression measurement instrument and number of subjects
per study, revealed interesting results. The ORs for
diagnostic interviews were significantly higher than those
for self-rating instruments for all-cause mortality. This
makes sense, as the fact that studies using (semi-)structured
diagnostic interviews categorize patients with more severe
depressive symptoms as depressed, whereas studies using
self-rating instruments may include more patients, as they
often include patients with mild and moderate depressive
symptoms as well. Major depression is likely to have a
stronger association with adverse outcomes than less severe
depressive symptoms when there is a dose–response
relationship. In addition, it has been suggested that standard
cutoff scores for self-rating instruments lead to an overes-
timation of depression severity. More nondepressed patients
may be rated as depressed than when structured diagnostic
interviews are used. This can explain why the strength of the
association between post-MI depression and prognosis is
weaker for depression assessed with self-rating instruments
than for structured interview-based instruments.
Contrasting results were found in other meta-analyses on
depression in CHD patients. Nicholson et al. [7] found that
studies using clinical measures of depression reported
weaker associations between depression and prognosis
than did studies using symptom assessments. Barth et al.
[6] found no difference in the association between post-MI
depression and prognosis as measured with (semi-)structured
diagnostic interviews or self-report instruments and progno-
sis. In the current meta-analysis, smaller studies did not
report significantly higher ORs than did larger studies, and
sample size did not change over time. This indicates that
publication bias did not affect the results.5. Conclusion
This meta-analysis shows that depression has been
consistently associated with a worse prognosis after MI
over the past 25 years. The association between post-MI
depression and impaired prognosis is stable over time for
mortality, but shows a slight decline for new cardiac events.
These results once again emphasize that depression in post-
MI patients not only deserves attention as a debilitating
215A. Meijer et al. / General Hospital Psychiatry 33 (2011) 203–216condition in itself but also remains a signal of an increased
risk of cardiovascular events and mortality.
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PubMed
(“mood disorders” [MeSH] OR depression [MeSH] OR
depression [tiab] OR depressive [tiab]) AND (“myocardial
infarction” [MeSH] OR “myocardial infarction” [tiab])
through January 5, 2011, humans only
Embase
(“mood disorder” OR “depressive symptoms” OR
“depressive symptomatology” OR depressed)
AND
(“heart infarction” OR “myocardial infarction”)
through January 5 2011, map to preferred terminology,
explosion search, search terms must be major focus, search
humans only, Embase only.
Psychinfo
((major depression) OR depression OR depressive)
AND
((myocardial infarctions) OR (myocardial infarction))
through January 5, 2011, humans only
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